CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.
Laura MagginoGiuseppe MalleoStefano CrippaGiulio BelfioriSara NobileGiulia GaspariniGabriella LionettoClaudio LuchiniPaola MattioloMarco Schiavo-LenaClaudio DoglioniAldo ScarpaClaudio BassiMassimo FalconiRoberto SalviaPublished in: Annals of surgical oncology (2022)
Recurrence following post-neoadjuvant pancreatectomy is common. Preoperative tumor size <20 mm, normal posttreatment CA19.9 and ΔCA19.9 > 50% were associated with longer RFS. These variables should not be taken in isolation, as their interaction significantly modulates the recurrence risk.